The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration-Reference-Cited by-同舟云学术

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration

Published:2016-10 Issue:10 Volume:5 Page:1048-1056
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Villani Linda A.,Smith Brennan K.,Marcinko Katarina,Ford Rebecca J.,Broadfield Lindsay A.,Green Alex E.,Houde Vanessa P.,Muti Paola,Tsakiridis Theodoros,Steinberg Gregory R.

Funder

Canadian Cancer Society

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference41 articles.

1. Apple trees to sodium-glucose co-transporter inhibitors: a review of SGLT2 inhibition;White;Clinical Diabetes,2010

2. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus;Scheen;Drugs,2015

3. Potential applications for biguanides in oncology;Pollak;Journal of Clinical Investigation,2013

4. Metformin: from mechanisms of action to therapies;Foretz;Cell Metabolism,2014

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies;European Journal of Pharmacology;2024-09

2. Obesity-Associated Colorectal Cancer;International Journal of Molecular Sciences;2024-08-14

3. Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2024-08-06

4. The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data;Cell Reports Medicine;2024-08

5. Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: a population-based cohort study;Diabetes & Metabolism;2024-08